Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273.
|
3771562 |
1986 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The prothrombin sample used was from a heterozygote but contained exclusively a defective prothrombin molecule, since the patient was heterozygous for both dysprothrombinemia and hypoprothrombinemia.
|
3567158 |
1987 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382.
|
3242619 |
1988 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His).
|
1421398 |
1992 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion.
|
17002658 |
2006 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Prophylactic administration of prothrombin complex concentrates for congenital prothrombin deficiency with a novel frameshift mutation, prothrombin saitama.
|
23152198 |
2013 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
True congenital prothrombin deficiency due to a 'new' mutation in the pre-propeptide (ARG-39 GLN).
|
18852482 |
2008 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Determination of the amino acid substitution in human prothrombin type 3 (157 Glu leads to Lys) and the localization of a third thrombin cleavage site.
|
6405779 |
1983 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia.
|
1349838 |
1992 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin.
|
3801671 |
1987 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A patient with a severe bleeding tendency and hypoprothrombinemia (Factor II activity 2%, Factor II antigen 5%) was screened for the presence of alterations in his prothrombin gene.
|
7740448 |
1994 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly.
|
14962227 |
2004 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala.
|
7792730 |
1995 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362 --> Thr (Prothrombin Vellore 1) mutation.
|
15892853 |
2005 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site.
|
7865694 |
1994 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The abnormal prothrombin gene of an Italian patient with a severe bleeding tendency and hypoprothrombinemia was selected for study and compared with the prothrombin genes of healthy controls.
|
9134629 |
1997 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity.
|
2719946 |
1989 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.
|
1354985 |
1992 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hypoprothrombinemia (OR 1.676, 95% CI 1.275-2.203) and prothrombin time (PT) prolongation (OR 2.050, 95% CI 1.398-3.005) were significantly associated with NMTT-cephalosporins, whereas bleeding was not (OR 1.359, 95% CI 0.920-2.009).
|
31623191 |
2019 |
Disseminated Intravascular Coagulation
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The disseminated intravascular coagulation (DIC) score, which is based on readily available and relatively inexpensive coagulation parameters, including platelet count, fibrin-related markers, prothrombin time and fibrinogen, has not been reported regarding PVT development in cirrhotic patients to date.
|
29178991 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Secondary outcomes included platelet count, disseminated intravascular coagulation (DIC), and prothrombin time (PT).
|
30064685 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In Swiss albino mice, intraperitoneal injection of PAF causes sudden death with oxidative stress and disseminated intravascular coagulation (DIC), characterized by prolonged prothrombin time, thrombocytopenia, reduced fibrinogen content, and increased levels of fibrinogen degradation products.
|
31442556 |
2019 |
Thrombophilia
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Factor V Leiden (FVL) and prothrombin gene (G20210A) mutations are the most common types of hereditary thrombophilias, but are usually undiagnosed because most carriers are asymptomatic.
|
15006834 |
2004 |
Thrombophilia
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease.
|
9409210 |
1997 |
Thrombophilia
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The important polymorphisms leading to inherited thrombophilia are Factor V Leiden (FVL), Prothrombin G20210A and MTHFR C677T and A1298C.
|
26135458 |
2016 |